VERAGEL-DMS Tablet (2022)

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

1. Name of the medicinal product

Vveragel-DMS Tablet.

2. Qualitative and quantitative composition

Each tablet contains: Aluminum Hydroxide-Magnesium Carbonate Co-precipitate 325 mg Dimethylpolysiloxane 10 mg Dicyclomine HCl 2.5 mg There are no potentially sensitizing inactive ingredients in the ...

3. Pharmaceutical form

Tablet.

4.1. Therapeutic indications

For the management and treatment of hyperacidity, gastritis and Please consult a doctor or a pharmacist for further peptic ulcer.

4.2. Posology and method of administration

Dosage / Times of administration 1 to 2 tablets four times a day, to be taken 1 hour after meals and at bedtime or, as recommended by a doctor. Method of administration Oral administration.

4.8. Undesirable effects

Constipation may result due to the Aluminum hydroxide or at times diarrhea due to the magnesium carbonate component. In either case, temporarily discontinue the drug for a couple of days then resume by ...

6.4. Special precautions for storage

Medicine should not be exposed to sunlight and should be stored at temperature not exceeding 30°C.

7. Marketing authorization holder

UNILAB, Inc., No. 66 United Street, Mandaluyong City, Metro Manila, Philippines Imported by: Goldplus Universal Pte Ltd, 103 Kallang Avenue #06-02, Singapore 339504.